Biblio
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth. Nat Commun. 2024;15(1):1359.
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia. Cancer Cell Int. 2023;23(1):202.
.